New influenza A (H1N1) pandemia and cancer patients: What do we do?;Nouvelle pandémie de grippe A (H1N1): Que faire pour les patients atteints d'un cancer?

Bulletin du Cancer

Volumn 96, Issue 11, 2009, Pages 1045-1052

  Barriere J ^a   Otto, J ^a   Cua, E ^b   Coindard, G ^c   Peyrade, F ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c UFR Médecine Paris Sud   (France)

Author keywords

Cancer; Influenza A (H1N1); Influenza vaccination; Oseltamivir; Recommendations

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR; ANTIVIRUS AGENT; STREPTOCOCCUS VACCINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL ISOLATION; DISEASE SEVERITY; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NEUTROPENIA; NEUTROPHIL COUNT; PANDEMIC; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; EPIDEMIC; HOSPITALIZATION; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; NEOPLASM;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEOPLASMS; NEUTROPENIA; OSELTAMIVIR; STREPTOCOCCAL VACCINES;

EID: 73349102513     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0962     Document Type: Article

References (26)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009 18 ; 360 : 2605-15.
2. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009 ; 361 : 674-9.
3. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009 ; 58 : 536-41.
4. Cooksley CD, Avritscher EB, Bekele BN, Rolston KV, Geraci JM, Elting LS. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005 ; 104 : 618-28.
5. Melcher L. Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy. Clin Oncol (R Coll Radiol) 2005 ; 17 : 12-5.
6. Loulergue P, Mir O, Alexandre J, Ropert S, Goldwasser F, Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008 ; 19 : 1658.
7. Ring A, Marx G, Steer C, Prendiville J, Ellis P. Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy. Int J Clin Pract 2003 ; 57 : 542-3.
8. Mah MW, Hagen NA, Pauling-Shepard K, Hawthorne JS, Mysak M, Lye T, et al. Understanding influenza vaccination attitudes at a Canadian cancer center. Am J Infect Control 2005 ; 33 : 243-50.
9. Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005 ; 55 (Suppl 1) : i5-i21.
10. Zimmer SM, Burke DS. Historical perspective - Emergence of influenza A (H1N1) viruses. N Engl J Med 2009 ; 361 : 279-85.
11. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009 ; 361 : 680-9.
12. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med 2008 ; 359 : 2579-85.
13. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007 ; 45 : 1568-75.
14. Vu D, Peck AJ, Nichols WG, Varley C, Englund JA, Corey L, et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis 2007 ; 45 : 187-93.
15. Herzog NS, Bratzler DW, Houck PM, Jiang H, Nsa W, Shook C, et al. Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia. Am J Med 2003 ; 115 : 454-61.
16. Gross PA, Gould AL, Brown AE. Effect of cancer chemotherapy on the immune response to influenza virus vaccine : review of published studies. Rev Infect Dis 1985 ; 7 : 613-8.
17. Brydak LB, Guzy J, Starzyk J, Machała M, Góź dź SS. Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer 2001 ; 9 : 65-8.
18. Nordøy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, et al. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 2002 ; 19 : 71-8.
19. Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 2005 ; 3 : 214-20.
20. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000 ; 82 : 1261-5.
21. Centkowski P, Brydak L, Machała M, Kalinka-Warzocha E, Błasińska-Morawiec M, Federowicz I, et al. Polish Lymphoma Research Group. Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma. J Clin Immunol 2007 ; 27 : 339-46.
22. Ljungman P, Nahi H, Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine : a randomised study. Br J Haematol 2005 ; 130 : 96-8.
23. Ramanathan RK, Potter DM, Belani CP, Jacobs SA, Gravenstein S, Lim F, et al. Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients. J Clin Oncol 2002 ; 20 : 4313-8.
24. Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, Rolston KV, et al. Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer 2007 ; 109 : 2357-64.
25. Earle CC. Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 2003 ; 21 : 1161-6.
26. Sommer AL, Wachel BK, Smith JA. Evaluation of vaccine dosing in patients with solid tumors receiving myelosuppressive chemotherapy. J Oncol Pharm Pract 2006 ; 12 : 143-54.